AZTA · Azenta Inc
United States · RS rating 93 · As of 2026-10-14
| Price | 37.18 USD |
|---|---|
| 1-day change | -1.8% |
| RS rating (overall / 1M / 3M / 12M) | 93 / 95 / 95 / 76 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 35 / 41 / 28 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -133.3% |
| Sales growth Q/Q | -6.5% |
| Distance from 52-week high | +13.0% |
| Market cap (USD) | $1.2B |